Enveric Biosciences Inc. is a pioneering pharmaceutical company based in Florida, dedicated to developing cannabinoid-based therapeutics that significantly improve treatment outcomes for cancer patients. By leveraging its deep expertise in cannabinoid research, Enveric is focused on creating innovative drug candidates that target unmet medical needs and enhance the quality of life for individuals battling cancer. With a strong emphasis on clinical development, the company is strategically positioned to capitalize on the expanding convergence of cannabinoid science and oncology, ultimately aiming to transform cancer care.
Click "Analyze" to generate stock analysis
ENVB Price Trend and Signals
ENVB Financials
2025-10-28Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-28Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-28Bullishprice_signal
Large price change detected: 1067.21%.
2025-10-27Bearishmacd_signal
Dead cross below zero detected.
2025-10-27Somewhat Bearishprice_signal
Monthly low detected.
2025-10-15Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-15Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-15Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-15Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.